Oklahoma OTC Manufacturer Cited for Multiple Violations
The FDA hit OTC drug manufacturer Tomco-Harwel Industries with an extensive Form 483 for numerous violations at its Tulsa, Oklahoma facility.
Source: Drug Industry Daily
The FDA hit OTC drug manufacturer Tomco-Harwel Industries with an extensive Form 483 for numerous violations at its Tulsa, Oklahoma facility.
Source: Drug Industry Daily